Concepedia

Publication | Closed Access

Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia

DOI

213

Citations

20

References

2011

Year

Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Shahrbano Rostami, Seyed H. Ghaffari, Mohamad Jahani, Massoud Iravani, Seyed Asadollah Mousavi, Babak Bahar, Mahdi Jalili
Journal of Clinical Oncology

Abstract

The long-term follow-up of newly diagnosed patients with APL treated with single-agent arsenic trioxide shows high rates of DFS and OS.

References

YearCitations

Page 1